Page results
-
Your treatment for acute lymphoblastic leukaemia (ALL) will be delivered within a number of comprehensive specialised services led by medical and nursing cancer care experts.
-
UCLH is contributing to a national priority trial of the drug ruxolitinib in patients with Covid-19 pneumonia (infection of the lungs).
-
Patient information who have been recommended to use a Biatain® dressing on your skin that has broken down due to your radiotherapy or proton beam therapy treatment.
-
Update about our hospital on Gray's Inn Road
-
Short videos on managing cancer pain, cancer-related fatigue and improving sleep
-
Information for patients from overseas visiting UCLH hospitals.
-
At UCLH we run seasonal COVID-19 vaccination clinics from our Hospital Hub within UCH. Vaccinations are available to members of the eligible public as well as UCLH patients.
-
Health secretary Matt Hancock visited University College Hospital yesterday to see for himself our post-Covid-19 service set up to help survivors of the virus with their long-term recovery.
-
A large study looking at the experiences of people across England after giving birth by Caesarean section has highlighted disparities in outcomes between patients of different ethnic groups.
-
A multiple sclerosis (MS) patient in the UK is the first to receive CAR T cell therapy in a UCLH clinical trial testing whether this personalised treatment may slow or even halt the progression of the disease.
File results
-
FOI/2022/0134 - Plastic laminating pouches/ sleeves purchased
-
FOI/2022/0140 - Early neo-natal deaths and babies born with serious brain injury
-
FOI/2022/0141 - Idiopathic pulmonary fibrosis (IPF) quality standard
-
FOI/2022/0145 - Head and neck cancer drug treatments
-
FOI/2022/0147 - Oesophageal and gastric cancer drug treatments
-
FOI/2022/0148 - Maternity related overseas services
-
FOI/2022/0150 - Hepatocellular carcinoma drug treatments
-
FOI/2022/0151 - Omnipod patch pump
-
FOI/2022/0153 - Central water treatment equipment for renal dialysis
-
FOI/2022/0154 - Immunoglobulin treatments (for any disease)